GM-CSF regulates the ERK1/2 pathways and protects injured retinal ganglion cells from induced death

Experimental Eye Research

Volumn 89, Issue 5, 2009, Pages 665-677

  Schallenberg, Maurice ^a,b   Charalambous, Petar ^a   Thanos, Solon ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

axotomy; ganglion cell line; GM CSF; neuroprotection; retina; staurosporine

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; FLUOROGOLD; GLUTAMIC ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ALPHA RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAD; PROTEIN BCL 2; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL LABELING; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLAUCOMA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; NERVE CELL NECROSIS; NERVE FIBER TRANSECTION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; RETINA; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; AGED; ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BLOTTING, WESTERN; BUTADIENES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GLAUCOMA; GLUTAMIC ACID; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYDROXYLAMINES; MAP KINASE KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUROANATOMICAL TRACT-TRACING TECHNIQUES; NITRILES; OPTIC NERVE INJURIES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; RETINAL GANGLION CELLS; STAUROSPORINE;

EID: 70349469686     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.06.008     Document Type: Article

References (44)

1. Amar A.P., and Levy M.L. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44 (1999) 1027-1040
2. Armitage J.O. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood 92 (1998) 4491-4508
3. Baldwin G.C., Benveniste E.N., Chung G.Y., Gasson J.C., and Golde D.W. Identification and characterization of a high-affinity granulocyte-macrophage colony-stimulating factor receptor on primary rat oligodendrocytes. Blood 82 (1993) 3279-3282
4. Bouhy D., Malgrange B., Multon S., Poirrier A.L., Scholtes F., Schoenen J., et al. Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J. 20 (2006) 1239-1241
5. Cao X.Q., Arai H., Ren Y.R., Oizumi H., Zhang N., Seike S., et al. Recombinant human granulocyte colony-stimulating factor protects against MPTP-induced dopaminergic cell death in mice by altering bcl-2/Bax expression levels. J. Neurochem. 99 (2006) 861-867
6. Chao J.R., Wang J.M., Lee S.F., Peng H.W., Lin Y.H., Chou C.H., Li J.C., Huang H.M., Chou C.K., Kuo M.L., Yen J.J., and Yang-Yen H.F. mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response. Mol. Cell. Biol. 18 (1998) 4883-4898
7. Choi J.K., Choi B.H., Ha Y., Park H., Yoon S.H., Park H.C., et al. Signal transduction pathways of GM-CSF in neural cell lines. Neurosci. Lett. 420 (2007) 217-222
8. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., and Beattie M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3 (1997) 73-76
9. Dame J.B., Christensen R.D., and Juul S.E. The distribution of granulocyte-macrophage colony-stimulating factor and its receptor in the developing human fetus. Pediatr. Res. 46 (1999) 358-366
10. David S., and Ousman S.S. Recruiting the immune response to promote axon regeneration in the injured spinal cord. Neuroscientist 8 (2002) 33-41
11. Fischer D., Heiduschka P., and Thanos S. Lens-injury-stimulated axonal regeneration throughout the optic pathway of adult rats. Exp. Neurol. 172 (2001) 257-272
12. Fischer D., Pavlidis M., and Thanos S. Cataractogenic lens injury prevents traumatic ganglion cell death and promotes axonal regeneration both in vivo and in culture. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3943-3954
13. Fuo Q.L., Wu W., Wang H., Li X., Lee V.W., and So K.F. Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension. Cell. Mol. Neurobiol. 28 (2008) 317-329
14. Grimm C., Hermann D.M., Bogdanova A., Hotop S., Kilic U., Wenzel A., Kilic E., and Gassmann M. Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration. Semin. Cell Dev. Biol. 16 (2005) 531-538
15. Guillemin G., Boussin F.D., Le Grand R., Croitoru J., Coffigny H., and Dormont D. Granulocyte macrophage colony stimulating factor stimulates in vitro proliferation of astrocytes derived from simian mature brains. Glia 16 (1996) 71-80
16. Guo L., Salt T.E., Maass A., Luong V., Moss S.E., Fitzke F.W., and Cordeiro M.F. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Invest. Ophthalmol. Vis. Sci. 47 (2006) 626-633
17. Ha Y., Kim Y.S., Cho J.M., Yoon S.H., Park S.R., Yoon D.H., et al. Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury. J. Neurosurg. Spine 2 (2004) 55-61
18. Hasselblatt M., Ehrenreich H., and Sirén A.L. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J. Neurosurg. Anesthesiol. 18 (2006) 132-138
19. Huang X., Choi J.K., Park S.R., Ha Y., Park H., Yoon S.H., et al. GM-CSF inhibits apoptosis of neural cells via regulating the expression of apoptosis-related proteins. Neurosci. Res. 58 (2007) 50-57
20. Isenmann S., Wahl C., Krajewski S., Reed J.C., and Bahr M. Up-regulation of bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. Eur. J. Neurosci. 9 (1997) 1763-1772
21. Kilic E., Kilic U., Bassetti C.L., Gassmann M., and Herman D.M. Brain-derived erythropoietin protects from local cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J. 19 (2005) 2026-2028
22. Kilic U., Kilic E., Soliz J., Bassetti C.L., Gassmann M., and Herman D.M. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J. 19 (2005) 249-251
23. Kim J.K., Choi B.H., Park H.C., Park S.R., Kim Y.S., Yoon S.H., et al. Effects of GM-CSF on the neural progenitor cells. Neuroreport 15 (2004) 2161-2165
24. Krüger C., Cira D., Sommer C., Fischer A., Schäbitz W.R., and Schneider A. Long-term gene expression changes in the cortex following cortical ischemia revealed by transcriptional profiling. Exp. Neurol. 200 (2006) 135-152
25. Leon S., Yin Y., Nguyen J., Irwin N., and Benowitz L.I. Lens injury stimulates axon regeneration in the mature rat optic nerve. J. Neurosci. 20 (2000) 4615-4626
26. Liu X.Z., Xu X.M., Hu R., Du C., Zhang S.X., McDonald J.W., Dong H.X., Wu Y.J., Fan G.S., Jacquin M.F., Hsu C.Y., and Choi D.W. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17 (1997) 5395-5406
27. Liva S.M., Kahn M.A., Dopp J.M., and de Vellis J. Signal transduction pathways induced by GM-CSF in microglia: significance in the control of proliferation. Glia 26 (1999) 344-352
28. McKernan D.P., and Cotter T.G. A critical role for Bim in retinal ganglion cell death. J. Neurochem. 102 (2007) 922-930
29. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339 (1989) 27-30
30. Meuer K., Pitzer C., Teismann P., Kruger C., Goricke B., Laage R., et al. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J. Neurochem. 97 (2006) 675-686
31. Moore S., and Thanos S. The concept of microglia in relation to central nervous system disease and regeneration. Prog. Neurobiol. 48 (1996) 441-460
32. Müller A., Hauk T.G., and Fischer D. Astrocyte-derived CNTF switches mature RGCs to a regenerative state following inflammatory stimulation. Brain 130 (2007) 3308-3320
33. Nicola N.A. GM-CSF receptor. In: Oppenheim J.J., and Feldman M. (Eds). Cytokine Reference (2001), Academic Press, San Diego, CA 1935-1944
34. Park H.C., Shim Y.S., Ha Y., Yoon S.H., Park S.R., Choi B.H., et al. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng. 11 (2004) 913-922
35. Reed J.A., Clegg D.J., Smith K.B., Tolod-Richer E.G., Matter E.K., Picard L.S., et al. GM-CSF action in the CNS decreases food intake and body weight. J. Clin. Invest. 115 (2005) 3035-3044
36. Rickman D.W., Nacke R.E., and Bowes Rickman C. Characterization of the cell death promoter, Bad, in the developing rat retina and forebrain. Brain Res. Dev. Brain Res. 115 (1999) 41-47
37. Schäbitz W.R., Kruger C., Pitzer C., Weber D., Laage R., Gassler N., et al. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J. Cereb. Blood Flow Metab. 28 (2008) 29-43
38. Schäbitz W.R., and Schneider A. New targets for established proteins: exploring G-CSF for the treatment of stroke. Trends Pharmacol. Sci. 28 (2007) 157-161
39. Schneider A., Krüger C., Steigleder T., Weber D., Pitzer C., Laage R., Aronowski J., Maurer M.H., Gassler N., Mier W., Hasselblatt M., Kollmar R., Schwab S., Sommer C., Bach A., Kuhn H.G., and Schäbitz W.R. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 115 (2005) 2083-2098
40. Sucher N.J., Lipton S.A., and Dreyer E.B. Molecular basis of glutamate toxicity in retinal ganglion cells. Vis. Res. 37 (1997) 3483-3493
41. Suzumura A., Sawada M., Yamamoto H., and Marunouchi T. Effects of colony stimulating factors on isolated microglia in vitro. J. Neuroimmunol. 30 (1990) 111-120
42. Yamasaki M., Mishima H.K., Yamashita H., Kashiwagi K., Murata K., Minamoto A., and Inaba T. Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res. 1050 (2005) 15-26
43. Yin Y., Cui Q., Li Y., Irwin N., Fischer D., Harvey A.R., and Benowitz L.I. Macrophage-derived factors stimulate optic nerve regeneration. J. Neurosci. 23 (2003) 2284-2293
44. Yin Y., Henzl M.T., Lorber B., Nakazawa T., Thomas T.T., Jiang F., Langer R., and Benowitz L.I. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat. Neurosci. 9 (2000) 843-852